Identification Module
The Identification Module contains basic identifying information about the clinical trial, including the NCT ID, brief title, official title, acronym, organization study ID information, and organization details. This module provides essential identifiers for the trial.
Identification Module path is as follows:
Study -> Protocol Section -> Identification Module
Identification Module
Ignite Creation Date:
2025-12-24 @ 8:03 PM
Ignite Modification Date:
2025-12-24 @ 8:03 PM
NCT ID:
NCT02164604
Brief Title:
Lucentis to Treat Retinopathy of Prematurity (ROP) 3 Plus Disease
Official Title:
Intravitreal Ranibizumab to Treat Retinopathy of Prematurity Stage 3 Plus Disease
Study:
NCT02164604
Protocol Section:
NCT02164604